Asian Medical Tourism to Cross US$5 Billion by 2012

By Shushmul Maheshwari
RNCOS E-Services Pvt. Ltd.
Email: press@rncos.com
http://www.rncos.com/

Tuesday - June 30, 2009

Medical tourism is emerging as one of the fastest growing markets in Asia, with the rising number of foreign tourists coming for their treatments into the region. Our report "Asian Medical Tourism Analysis (2008-2012)" has found that medical tourism market has recorded a reasonable growth of around 11% over 2007 to reach at US$ 3.8 Billion in 2008. One of the main reasons for the growth of the industry is the low cost of the treatments and the world-class services.

"The patients are ready to take up treatments in the countries like Thailand, India, and Singapore despite the financial crisis that eroded the purchasing power of the foreign tourists," said a research analyst at RNCOS.

Various countries that are the most sought after destinations for the medical tourists' arriving to Asia are - Malaysia, India, Thailand, Singapore, Philippines and South Korea. Thailand and Singapore are the leading destinations for medical tourism that together accounted for 64% of the total Asian medical tourism market in 2008.

These countries offer various complex treatments at affordable costs. The cost of some highly sophisticated treatments such as hip replacement, heart valve replacement is 8-10 times lower in India and Thailand than in the United States. Also, foreign tourists get their treatments like cardiac procedures done in the Asian countries like Thailand and India in a week or two, whereas it takes nearly a year to get treated in developed countries.

The future prospect of the medical tourism industry seems encouraging. The Asian countries will continue leveraging from their highly developed health infrastructure such as well-qualified medical professionals, internationally accredited healthcare in stitutions and the hot spot destinations. The Asian region, mainly comprising of India, Thailand, Singapore, Malaysia, Philippines and South Korea is expected to receive 6.1 Million medical tourists by the end of 2012.

The report "Asian Medical Tourism Analysis (2008-2012)" provides a deep insight about the emerging medical tourism markets in Asia, the market trends responsible for the present performance of the industry and the future growth potential of the industry. It provides key information to clients looking ahead to venture into these markets as well as helps them to plan out strategies before going for an investment/partnership in the concerned markets.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM105.htm

Check DISCOUNTED REPORTS on: http://www.rncos.com

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.

Published at Investorideas.com Financial Article Feed : http://www.investorideas.com/RSS/feeds/II-Art.xml
About InvestorIdeas.com: One of the first online investor resources providing in-depth information on renewable energy, greentech and water sectors.

Become an Investorideas.com Member
Gain Exclusive Insight on Leading Sectors, Global Trends, and Insider Trading Ideas, News, Articles, renewable energy and water stocks directory.
Learn more: http://www.investorideas.com/membership

Sign up for free newsletter, stock and sector news alerts at Investorideas.com
click here: http://www.investorideas.com/Resources/Newsletter.asp

Disclaimer: The views and opinions expressed in the research published are those of the individual companies and writers and not necessarily those of Investorideas.comŽ, or any of the industry sector portals . At the time of publication, writers may hold positions in the stocks or companies mentioned.

Investorideas.comŽ or any of the industry sector portals cannot assure accuracy of the research presented. Investors are encouraged to research and verify facts and under no circumstances is Investorideas.comŽ endorsing the content as a recommendation to buy or sell stock.